Safety of TNF-α inhibitors during IBD pregnancy: a systematic review

[31] Jarnum S(2006)Effect of intentional infliximab use throughout pregnancy in inducing and maintaining remission in Crohn’s disease Dig Liver Dis 38 439-77

[32] Nielsen OH(2013)Safety of thiopurines and anti-TNF-alpha drugs during pregnancy in patients with inflammatory bowel disease Am J Gastroenterol 108 433-64

[33] Andreasson B(2012)Serious infection and mortality in patients with Crohn’s disease: more than 5 years of follow-up in the TREAT registry Am J Gastroenterol 107 1409-869

[34] Bondesen S(2013)Biologic therapy in pregnancy and inflammatory bowel disease: a prospective 7 year study: clinical outcome J Crohns Colitis 7 S243-1306

[35] Jacobsen O(2013)Pregnancy outcomes in women with inflammatory bowel disease exposed to infliximab J Crohns Colitis 7 S170-2392

[36] Jarnum S(2013)Adalimumab and infliximab therapy during pregnancy in IBD: a prospective assessment of outcome, safety and cord blood levels J Crohns Colitis 7 S252-1058

[37] Ferguson CB(2011)Inflammatory bowel disease in pregnancy: report of a case treated with infliximab and litterature review Ir J Med Sci 180 S131-379

[38] Mahsud-Dornan S(2011)Biological treatment of patient with ulcerative colitis during pregnancy Cesk Sloven Gastroent Hepatol 65 75-1854

[39] Patterson RN(2012)Is safety infliximb during pregnancy in patients with inflammatory bowel disease? Rev Esp Enferm Dig 104 59-592

[40] Mahadevan U(2012)Pregnancy and newborn outcome of mothers with inflammatory bowel disease exposed to anti-TNF-alpha therapy during pregnancy J Crohns Colitis 6 S157-641

[31] Jarnum S(2006)Effect of intentional infliximab use throughout pregnancy in inducing and maintaining remission in Crohn’s disease Dig Liver Dis 38 439-77

[32] Nielsen OH(2013)Safety of thiopurines and anti-TNF-alpha drugs during pregnancy in patients with inflammatory bowel disease Am J Gastroenterol 108 433-64

[33] Andreasson B(2012)Serious infection and mortality in patients with Crohn’s disease: more than 5 years of follow-up in the TREAT registry Am J Gastroenterol 107 1409-869

[34] Bondesen S(2013)Biologic therapy in pregnancy and inflammatory bowel disease: a prospective 7 year study: clinical outcome J Crohns Colitis 7 S243-1306

[35] Jacobsen O(2013)Pregnancy outcomes in women with inflammatory bowel disease exposed to infliximab J Crohns Colitis 7 S170-2392

[36] Jarnum S(2013)Adalimumab and infliximab therapy during pregnancy in IBD: a prospective assessment of outcome, safety and cord blood levels J Crohns Colitis 7 S252-1058

[37] Ferguson CB(2011)Inflammatory bowel disease in pregnancy: report of a case treated with infliximab and litterature review Ir J Med Sci 180 S131-379

[38] Mahsud-Dornan S(2011)Biological treatment of patient with ulcerative colitis during pregnancy Cesk Sloven Gastroent Hepatol 65 75-1854

[39] Patterson RN(2012)Is safety infliximb during pregnancy in patients with inflammatory bowel disease? Rev Esp Enferm Dig 104 59-592

[40] Mahadevan U(2012)Pregnancy and newborn outcome of mothers with inflammatory bowel disease exposed to anti-TNF-alpha therapy during pregnancy J Crohns Colitis 6 S157-641